AMR Action fund
![](https://niroglobal.com/wp-content/uploads/2023/04/Organization-Chart-2.png)
Initiative/Organisation
![](https://niroglobal.com/wp-content/uploads/2023/04/Goal.png)
Goal
The AMR Action Fund is a public-private partnership investing in the development of new antimicrobial therapeutics. It focuses investments in clinical-stage companies that are developing antimicrobial therapeutics for priority pathogens, as identified by the World Health Organization (WHO) and the Centers for Disease Control and Prevention (CDC).
![](https://niroglobal.com/wp-content/uploads/2023/04/Upward-2.png)
Open opportunities
The AMR Action Fund does not proactively issue calls for proposals. To introduce your company to the AMR Action Fund, use this Contact form.
![](https://niroglobal.com/wp-content/uploads/2023/04/Bull-Horn.png)
Call for proposals
N/A
![](https://niroglobal.com/wp-content/uploads/2023/04/Time-Table.png)
Application deadline
N/A
![](https://niroglobal.com/wp-content/uploads/2023/04/Cycle-1.png)
Next round of applications
N/A
![](https://niroglobal.com/wp-content/uploads/2023/04/Life-Sciences.png)
Opportunity type
Equity investments
![](https://niroglobal.com/wp-content/uploads/2023/04/Health-Check.png)
Eligibility criteria
The AMR Action Fund focuses investments in small- and mid-size biotech companies.
![](https://niroglobal.com/wp-content/uploads/2023/04/Executive-Board-Advisory.png)
Intellectual property policy
Unknown
![](https://niroglobal.com/wp-content/uploads/2023/04/Environmental.png)
Funding level
Unknown
![](https://niroglobal.com/wp-content/uploads/2023/04/Performance-Improvement.png)
Find out more
To connect with the AMR Action Fund, please click here.